Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications

被引:77
作者
Gilbert, RE
Dunn, DDT
Lightman, S
Murray, PI
Pavesio, CE
Gormley, PD
Masters, J
Parker, SP
Stanford, MR
机构
[1] UCL, Inst Child Hlth, Dept Epidemiol & Publ Hlth, Sch Med, London WC1N 1EH, England
[2] Moorfields Eye Hosp, Inst Ophthalmol, Dept Clin Ophthalmol, London EC1 2PD, England
[3] Univ Birmingham, Birmingham & Midland Eye Ctr, Acad Univ Ophthalmol, Birmingham B18 7QU, W Midlands, England
[4] St Thomas Hosp, Med Eye Unit, London SE1 7EH, England
关键词
D O I
10.1017/S0950268899002800
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Ocular disease is the commonest disabling consequence of toxoplasma infection. Incidence and lifetime risk of ocular symptoms were determined by ascertaining affected patients in a population-based, active reporting study involving ophthalmologists serving a population of 7.4 million. Eighty-seven symptomatic episodes were attributed to toxoplasma infection. Bilateral visual acuity of 6/12 or less was found in seven episodes (8 %) and was likely to have been transient in most cases. Black people born in West Africa had a 100-fold higher incidence of symptoms than white people born in Britain. Only two patients reported symptoms before 10 years of age. The estimated lifetime risk of symptoms in British born individuals (52 % of all episodes) was 18/100000 (95 % confidence interval: 10.8-25.2), The low risk and mild symptoms in an unscreened British population indicate limited potential benefits of prenatal or postnatal screening. The late age at presentation suggests a mixed aetiology of postnatally acquired and congenital infection for which primary prevention may be appropriate, particularly among West Africans.
引用
收藏
页码:283 / 289
页数:7
相关论文
共 34 条
[1]   MATERNAL PREVALENCE OF TOXOPLASMA ANTIBODY BASED ON ANONYMOUS NEONATAL SEROSURVEY - A GEOGRAPHICAL ANALYSIS [J].
ADES, AE ;
PARKER, S ;
GILBERT, R ;
TOOKEY, PA ;
BERRY, T ;
HJELM, M ;
WILCOX, AH ;
CUBITT, D ;
PECKHAM, CS .
EPIDEMIOLOGY AND INFECTION, 1993, 110 (01) :127-133
[2]   MODELING AGE-SPECIFIC AND TIME-SPECIFIC INCIDENCE FROM SEROPREVALENCE - TOXOPLASMOSIS [J].
ADES, AE ;
NOKES, DJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (09) :1022-1034
[3]   Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the UK [J].
Allain, JP ;
Palmer, CR ;
Pearson, G .
JOURNAL OF INFECTION, 1998, 36 (02) :189-196
[4]  
ASPOCK H, 1992, SCAND J INFECT DIS, P32
[5]  
BRESLOW NE, 1987, DESIGN ANAL COHORT S, V2, P57
[6]   Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak [J].
Burnett, AJ ;
Shortt, SG ;
Isaac-Renton, J ;
King, A ;
Werker, D ;
Bowie, WR .
OPHTHALMOLOGY, 1998, 105 (06) :1032-1037
[7]  
CONYNVANSPAEDON.MA, 1991, THESIS NAT I PUBLIC
[8]   EVALUATION OF 5 COMMERCIAL ASSAYS FOR SCREENING ANTENATAL SERA FOR ANTIBODIES TO TOXOPLASMA-GONDII [J].
CUBITT, WD ;
ADES, AE ;
PECKHAM, CS .
JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (05) :435-438
[9]  
Dubey JP., 1988, Toxoplasmosis of animals and man, P41
[10]   ASSESSMENT OF IMMUNOGLOBULIN-M IMMUNOSORBENT AGGLUTINATION ASSAY (ISAGA) FOR DETECTING TOXOPLASMA SPECIFIC IGM [J].
DUFFY, KMT ;
WHARTON, PJ ;
JOHNSON, JD ;
NEW, L ;
HOLLIMAN, RE .
JOURNAL OF CLINICAL PATHOLOGY, 1989, 42 (12) :1291-1295